Concepedia

NM Hylton

NH

3

Publications

766

Citations

3

H-Index

2009

Active since

Affiliations

University of California, San Francisco(Current)

University of Alabama at Birmingham

University of Minnesota

NM Hylton is an author at University of California, San Francisco specializing in cancer therapeutics, clinical trials, and molecular oncology.

Top concepts

MedicineOncologyBreast CancerCancer TherapyClinical TrialsMolecular OncologyRadiation OncologyCancer EpidemiologyHealthPathology

Publications per year

2009–2018

3

Publications

3

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

AD Barker, C C Sigman, Kelloff Gj et al. · Clinical Pharmacology & Therapeutics · 2009 · 740 citations

Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL

Douglas Yee, A. DeMichele, Claudine Isaacs et al. · Cancer Research · 2018 · 16 citations

Breast Oncology, Disease Progression, Cancer Management +19

Abstract P6-11-04: The evaluation of ganitumab/metformin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 trial

Douglas Yee, Marco Paoloni, Laura van’t Veer et al. · Cancer Research · 2017 · 10 citations

Surgical Oncology, High-risk Breast Cancer, Cancer Epidemiology +15

Rows per page

1–3 of 3